The EuroFlow PIDOT external quality assurance scheme: enhancing laboratory performance evaluation in immunophenotyping of rare lymphoid immunodeficiencies
The PIDOT-EQAS allows laboratories, adhering to the standardized EuroFlow approach, to monitor interlaboratory variations without the need for sample distribution, and provides them educational support to recognize rare clinically relevant immunophenotypic patterns of primary immunodeficiencies (PID). This EQAS contributes to quality improvement of PID diagnostics and can serve as an example for future flow cytometry EQAS in the context of rare diseases.
Authors
- Filomeen Haerynck (ORCID: https://orcid.org/0000-0001-9161-7361)
- Carolien Bonroy (ORCID: https://orcid.org/0000-0002-9170-4200)
- Jacques J. M. van Dongen (ORCID: https://orcid.org/0000-0002-3650-7087)
- Naděžda Brdičková
- Martín Pérez‐Andrés (ORCID: https://orcid.org/0000-0003-4599-0776)
- Mattias Hofmans (ORCID: https://orcid.org/0000-0003-2061-7617)
- Tessa Kerre (ORCID: https://orcid.org/0000-0003-2114-2844)
- Jana Neirinck (ORCID: https://orcid.org/0000-0002-0084-9245)
- Malicorne Buysse
- Ciel De Vriendt (ORCID: https://orcid.org/0000-0002-5213-5391)
- Tomáš Kalina (ORCID: https://orcid.org/0000-0003-4475-2872)
- Alberto Orfao
- Xavier Bossuyt
Institutions
- Consejo Superior de Investigaciones Científicas (ES)
- Universidad de Salamanca (ES)
- Charles University (CZ)
- Ghent University Hospital (BE)
- Ghent University (BE)
- Instituto de Investigación Biomédica de Salamanca (ES)
- Centro de Investigación del Cáncer (ES)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
- KU Leuven (BE)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1515/cclm-2024-0749
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fonds Wetenschappelijk Onderzoek
- Instituto de Salud Carlos III